Loading…
Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation
DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the prod...
Saved in:
Published in: | Clinical chemistry (Baltimore, Md.) Md.), 2017-11, Vol.63 (11), p.1771-1773 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3 |
container_end_page | 1773 |
container_issue | 11 |
container_start_page | 1771 |
container_title | Clinical chemistry (Baltimore, Md.) |
container_volume | 63 |
creator | Peake, Roy W A Rodan, Lance H |
description | DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively. |
doi_str_mv | 10.1373/clinchem.2017.279497 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1958542463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1967314076</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</originalsourceid><addsrcrecordid>eNpdkEtLAzEQgIMotlb_gciCFy9b89o8jkWqVooK6nlJs1mbms3WZBfpvzelrQeZwzAz3wzDB8AlgmNEOLnVznq9NM0YQ8THmEsq-REYooLAXBQMHYMhhFDmElE-AGcxrlJJuWCnYIAlFJJgMgRP0265cY1yrbc6m2hb9cGqzPpM-Wzma-W77Md2y-zZ9KF17afVyqVZlb19Jeg1mGh8pzrb-nNwUisXzcU-j8DH_fT97jGfvzzM7ibzXBOBurziVFMiKl4hkYKY9Ao3jFBZCVmgxWIBIWM1VlgqBWFRY05qiAustx1RkRG42d1dh_a7N7ErGxu1cU550_axRLIQBcWUkYRe_0NXbR98-i5RjBNEIWeJojtKhzbGYOpyHWyjwqZEsNy6Lg-uy63rcuc6rV3tj_eLxlR_Swe55BeGUXrT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1967314076</pqid></control><display><type>article</type><title>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</title><source>Oxford Journals Online</source><creator>Peake, Roy W A ; Rodan, Lance H</creator><creatorcontrib>Peake, Roy W A ; Rodan, Lance H</creatorcontrib><description>DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively.</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1373/clinchem.2017.279497</identifier><identifier>PMID: 29089323</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Aciduria ; Brain Diseases, Metabolic, Inborn - diagnosis ; Brain Diseases, Metabolic, Inborn - genetics ; Central nervous system ; Child, Preschool ; Dehydrogenase ; Dehydrogenases ; Electroencephalography ; Female ; Humans ; Malonates - urine ; Medical screening ; Mitochondrial Proteins - genetics ; Nucleocytoplasmic Transport Proteins - genetics ; Purpura - diagnosis ; Purpura - genetics ; Skin ; Urine</subject><ispartof>Clinical chemistry (Baltimore, Md.), 2017-11, Vol.63 (11), p.1771-1773</ispartof><rights>Copyright American Association for Clinical Chemistry Nov 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</citedby><cites>FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29089323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peake, Roy W A</creatorcontrib><creatorcontrib>Rodan, Lance H</creatorcontrib><title>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</title><title>Clinical chemistry (Baltimore, Md.)</title><addtitle>Clin Chem</addtitle><description>DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively.</description><subject>Aciduria</subject><subject>Brain Diseases, Metabolic, Inborn - diagnosis</subject><subject>Brain Diseases, Metabolic, Inborn - genetics</subject><subject>Central nervous system</subject><subject>Child, Preschool</subject><subject>Dehydrogenase</subject><subject>Dehydrogenases</subject><subject>Electroencephalography</subject><subject>Female</subject><subject>Humans</subject><subject>Malonates - urine</subject><subject>Medical screening</subject><subject>Mitochondrial Proteins - genetics</subject><subject>Nucleocytoplasmic Transport Proteins - genetics</subject><subject>Purpura - diagnosis</subject><subject>Purpura - genetics</subject><subject>Skin</subject><subject>Urine</subject><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkEtLAzEQgIMotlb_gciCFy9b89o8jkWqVooK6nlJs1mbms3WZBfpvzelrQeZwzAz3wzDB8AlgmNEOLnVznq9NM0YQ8THmEsq-REYooLAXBQMHYMhhFDmElE-AGcxrlJJuWCnYIAlFJJgMgRP0265cY1yrbc6m2hb9cGqzPpM-Wzma-W77Md2y-zZ9KF17afVyqVZlb19Jeg1mGh8pzrb-nNwUisXzcU-j8DH_fT97jGfvzzM7ibzXBOBurziVFMiKl4hkYKY9Ao3jFBZCVmgxWIBIWM1VlgqBWFRY05qiAustx1RkRG42d1dh_a7N7ErGxu1cU550_axRLIQBcWUkYRe_0NXbR98-i5RjBNEIWeJojtKhzbGYOpyHWyjwqZEsNy6Lg-uy63rcuc6rV3tj_eLxlR_Swe55BeGUXrT</recordid><startdate>201711</startdate><enddate>201711</enddate><creator>Peake, Roy W A</creator><creator>Rodan, Lance H</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7QO</scope><scope>7RV</scope><scope>7TM</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201711</creationdate><title>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</title><author>Peake, Roy W A ; Rodan, Lance H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aciduria</topic><topic>Brain Diseases, Metabolic, Inborn - diagnosis</topic><topic>Brain Diseases, Metabolic, Inborn - genetics</topic><topic>Central nervous system</topic><topic>Child, Preschool</topic><topic>Dehydrogenase</topic><topic>Dehydrogenases</topic><topic>Electroencephalography</topic><topic>Female</topic><topic>Humans</topic><topic>Malonates - urine</topic><topic>Medical screening</topic><topic>Mitochondrial Proteins - genetics</topic><topic>Nucleocytoplasmic Transport Proteins - genetics</topic><topic>Purpura - diagnosis</topic><topic>Purpura - genetics</topic><topic>Skin</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peake, Roy W A</creatorcontrib><creatorcontrib>Rodan, Lance H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>https://resources.nclive.org/materials</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peake, Roy W A</au><au>Rodan, Lance H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><addtitle>Clin Chem</addtitle><date>2017-11</date><risdate>2017</risdate><volume>63</volume><issue>11</issue><spage>1771</spage><epage>1773</epage><pages>1771-1773</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>29089323</pmid><doi>10.1373/clinchem.2017.279497</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9147 |
ispartof | Clinical chemistry (Baltimore, Md.), 2017-11, Vol.63 (11), p.1771-1773 |
issn | 0009-9147 1530-8561 |
language | eng |
recordid | cdi_proquest_miscellaneous_1958542463 |
source | Oxford Journals Online |
subjects | Aciduria Brain Diseases, Metabolic, Inborn - diagnosis Brain Diseases, Metabolic, Inborn - genetics Central nervous system Child, Preschool Dehydrogenase Dehydrogenases Electroencephalography Female Humans Malonates - urine Medical screening Mitochondrial Proteins - genetics Nucleocytoplasmic Transport Proteins - genetics Purpura - diagnosis Purpura - genetics Skin Urine |
title | Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A32%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ethylmalonic%20Aciduria%20in%20an%20Infant%20with%20Neurological%20and%20Skin%20Presentation&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Peake,%20Roy%20W%20A&rft.date=2017-11&rft.volume=63&rft.issue=11&rft.spage=1771&rft.epage=1773&rft.pages=1771-1773&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1373/clinchem.2017.279497&rft_dat=%3Cproquest_cross%3E1967314076%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1967314076&rft_id=info:pmid/29089323&rfr_iscdi=true |